nodes	percent_of_prediction	percent_of_DWPC	metapath
Azelastine—CYP1A1—head and neck cancer	0.544	1	CbGaD
Azelastine—CYP2A6—Fluorouracil—head and neck cancer	0.0728	0.216	CbGbCtD
Azelastine—CYP2D6—Hydroxyurea—head and neck cancer	0.0599	0.178	CbGbCtD
Azelastine—CYP2C8—Fluorouracil—head and neck cancer	0.0359	0.107	CbGbCtD
Azelastine—CYP3A5—Docetaxel—head and neck cancer	0.0285	0.0846	CbGbCtD
Azelastine—CYP1A2—Fluorouracil—head and neck cancer	0.0278	0.0825	CbGbCtD
Azelastine—CYP2C9—Fluorouracil—head and neck cancer	0.025	0.0743	CbGbCtD
Azelastine—ABCB1—Vinblastine—head and neck cancer	0.0225	0.0668	CbGbCtD
Azelastine—CYP2D6—Vinblastine—head and neck cancer	0.0212	0.063	CbGbCtD
Azelastine—ABCB1—Docetaxel—head and neck cancer	0.0185	0.0551	CbGbCtD
Azelastine—CYP3A4—Vinblastine—head and neck cancer	0.0135	0.04	CbGbCtD
Azelastine—CYP3A4—Docetaxel—head and neck cancer	0.0111	0.033	CbGbCtD
Azelastine—Tearing eyes—Docetaxel—head and neck cancer	0.00402	0.0592	CcSEcCtD
Azelastine—Nasal discomfort—Fluorouracil—head and neck cancer	0.0032	0.0471	CcSEcCtD
Azelastine—Mucosal inflammation—Hydroxyurea—head and neck cancer	0.00229	0.0338	CcSEcCtD
Azelastine—Dysaesthesia—Fluorouracil—head and neck cancer	0.00211	0.0311	CcSEcCtD
Azelastine—Dysaesthesia—Docetaxel—head and neck cancer	0.00152	0.0225	CcSEcCtD
Azelastine—Amenorrhoea—Hydroxyurea—head and neck cancer	0.00144	0.0213	CcSEcCtD
Azelastine—Ulcer—Hydroxyurea—head and neck cancer	0.00134	0.0198	CcSEcCtD
Azelastine—Mucosal inflammation—Docetaxel—head and neck cancer	0.00119	0.0175	CcSEcCtD
Azelastine—Stinging—Fluorouracil—head and neck cancer	0.00113	0.0166	CcSEcCtD
Azelastine—Parosmia—Docetaxel—head and neck cancer	0.00102	0.015	CcSEcCtD
Azelastine—Lacrimation increased—Fluorouracil—head and neck cancer	0.000991	0.0146	CcSEcCtD
Azelastine—Herpes simplex—Fluorouracil—head and neck cancer	0.000991	0.0146	CcSEcCtD
Azelastine—Pharyngolaryngeal pain—Docetaxel—head and neck cancer	0.000977	0.0144	CcSEcCtD
Azelastine—Laryngeal pain—Docetaxel—head and neck cancer	0.000967	0.0143	CcSEcCtD
Azelastine—Ulcer—Fluorouracil—head and neck cancer	0.000966	0.0142	CcSEcCtD
Azelastine—Dermatitis contact—Fluorouracil—head and neck cancer	0.000903	0.0133	CcSEcCtD
Azelastine—Face oedema—Hydroxyurea—head and neck cancer	0.000889	0.0131	CcSEcCtD
Azelastine—Ageusia—Docetaxel—head and neck cancer	0.000814	0.012	CcSEcCtD
Azelastine—Amenorrhoea—Docetaxel—head and neck cancer	0.00075	0.0111	CcSEcCtD
Azelastine—Weight increased—Hydroxyurea—head and neck cancer	0.000725	0.0107	CcSEcCtD
Azelastine—Lacrimation increased—Docetaxel—head and neck cancer	0.000716	0.0105	CcSEcCtD
Azelastine—Hypoaesthesia—Vinblastine—head and neck cancer	0.000695	0.0102	CcSEcCtD
Azelastine—Pharyngitis—Vinblastine—head and neck cancer	0.000694	0.0102	CcSEcCtD
Azelastine—Influenza like illness—Docetaxel—head and neck cancer	0.00064	0.00944	CcSEcCtD
Azelastine—Nasopharyngitis—Fluorouracil—head and neck cancer	0.000593	0.00874	CcSEcCtD
Azelastine—Ill-defined disorder—Vinblastine—head and neck cancer	0.000565	0.00832	CcSEcCtD
Azelastine—Malaise—Vinblastine—head and neck cancer	0.000549	0.00808	CcSEcCtD
Azelastine—Vertigo—Vinblastine—head and neck cancer	0.000547	0.00805	CcSEcCtD
Azelastine—Upper respiratory tract infection—Fluorouracil—head and neck cancer	0.000533	0.00785	CcSEcCtD
Azelastine—Hypertension—Vinblastine—head and neck cancer	0.000525	0.00774	CcSEcCtD
Azelastine—Ill-defined disorder—Hydroxyurea—head and neck cancer	0.000515	0.00758	CcSEcCtD
Azelastine—Discomfort—Vinblastine—head and neck cancer	0.000512	0.00754	CcSEcCtD
Azelastine—Atrial fibrillation—Docetaxel—head and neck cancer	0.000505	0.00744	CcSEcCtD
Azelastine—Malaise—Hydroxyurea—head and neck cancer	0.0005	0.00737	CcSEcCtD
Azelastine—Conjunctivitis—Fluorouracil—head and neck cancer	0.000497	0.00732	CcSEcCtD
Azelastine—Epistaxis—Fluorouracil—head and neck cancer	0.000482	0.0071	CcSEcCtD
Azelastine—Sinusitis—Fluorouracil—head and neck cancer	0.000479	0.00706	CcSEcCtD
Azelastine—Discomfort—Hydroxyurea—head and neck cancer	0.000467	0.00688	CcSEcCtD
Azelastine—Rhinitis—Fluorouracil—head and neck cancer	0.00046	0.00678	CcSEcCtD
Azelastine—Hypoaesthesia—Fluorouracil—head and neck cancer	0.000456	0.00673	CcSEcCtD
Azelastine—Pharyngitis—Fluorouracil—head and neck cancer	0.000455	0.00671	CcSEcCtD
Azelastine—Infection—Hydroxyurea—head and neck cancer	0.00045	0.00663	CcSEcCtD
Azelastine—Paraesthesia—Vinblastine—head and neck cancer	0.000446	0.00657	CcSEcCtD
Azelastine—Nasopharyngitis—Docetaxel—head and neck cancer	0.000428	0.00631	CcSEcCtD
Azelastine—Pain—Vinblastine—head and neck cancer	0.000425	0.00626	CcSEcCtD
Azelastine—Constipation—Vinblastine—head and neck cancer	0.000425	0.00626	CcSEcCtD
Azelastine—Alanine aminotransferase increased—Docetaxel—head and neck cancer	0.000422	0.00622	CcSEcCtD
Azelastine—Feeling abnormal—Vinblastine—head and neck cancer	0.000409	0.00603	CcSEcCtD
Azelastine—Bronchospasm—Docetaxel—head and neck cancer	0.000407	0.006	CcSEcCtD
Azelastine—Gastrointestinal pain—Vinblastine—head and neck cancer	0.000406	0.00598	CcSEcCtD
Azelastine—Dyspnoea—Hydroxyurea—head and neck cancer	0.000404	0.00595	CcSEcCtD
Azelastine—Somnolence—Hydroxyurea—head and neck cancer	0.000403	0.00593	CcSEcCtD
Azelastine—Abdominal pain—Vinblastine—head and neck cancer	0.000393	0.00578	CcSEcCtD
Azelastine—Fatigue—Hydroxyurea—head and neck cancer	0.00039	0.00575	CcSEcCtD
Azelastine—Pain—Hydroxyurea—head and neck cancer	0.000387	0.00571	CcSEcCtD
Azelastine—Constipation—Hydroxyurea—head and neck cancer	0.000387	0.00571	CcSEcCtD
Azelastine—Weight increased—Docetaxel—head and neck cancer	0.000376	0.00555	CcSEcCtD
Azelastine—Vision blurred—Fluorouracil—head and neck cancer	0.000376	0.00555	CcSEcCtD
Azelastine—Feeling abnormal—Hydroxyurea—head and neck cancer	0.000373	0.0055	CcSEcCtD
Azelastine—Hypersensitivity—Vinblastine—head and neck cancer	0.000366	0.00539	CcSEcCtD
Azelastine—Conjunctivitis—Docetaxel—head and neck cancer	0.000359	0.00528	CcSEcCtD
Azelastine—Body temperature increased—Hydroxyurea—head and neck cancer	0.000358	0.00527	CcSEcCtD
Azelastine—Asthenia—Vinblastine—head and neck cancer	0.000356	0.00525	CcSEcCtD
Azelastine—Epistaxis—Docetaxel—head and neck cancer	0.000348	0.00513	CcSEcCtD
Azelastine—Chest pain—Fluorouracil—head and neck cancer	0.00034	0.00501	CcSEcCtD
Azelastine—Myalgia—Fluorouracil—head and neck cancer	0.00034	0.00501	CcSEcCtD
Azelastine—Diarrhoea—Vinblastine—head and neck cancer	0.00034	0.00501	CcSEcCtD
Azelastine—Discomfort—Fluorouracil—head and neck cancer	0.000336	0.00495	CcSEcCtD
Azelastine—Hypersensitivity—Hydroxyurea—head and neck cancer	0.000334	0.00492	CcSEcCtD
Azelastine—Rhinitis—Docetaxel—head and neck cancer	0.000332	0.00489	CcSEcCtD
Azelastine—Hypoaesthesia—Docetaxel—head and neck cancer	0.000329	0.00485	CcSEcCtD
Azelastine—Confusional state—Fluorouracil—head and neck cancer	0.000329	0.00484	CcSEcCtD
Azelastine—Pharyngitis—Docetaxel—head and neck cancer	0.000329	0.00484	CcSEcCtD
Azelastine—Dizziness—Vinblastine—head and neck cancer	0.000328	0.00484	CcSEcCtD
Azelastine—Anaphylactic shock—Fluorouracil—head and neck cancer	0.000326	0.0048	CcSEcCtD
Azelastine—Asthenia—Hydroxyurea—head and neck cancer	0.000325	0.00479	CcSEcCtD
Azelastine—Infection—Fluorouracil—head and neck cancer	0.000324	0.00477	CcSEcCtD
Azelastine—Visual impairment—Docetaxel—head and neck cancer	0.000319	0.0047	CcSEcCtD
Azelastine—Tachycardia—Fluorouracil—head and neck cancer	0.000318	0.00469	CcSEcCtD
Azelastine—Vomiting—Vinblastine—head and neck cancer	0.000316	0.00465	CcSEcCtD
Azelastine—Headache—Vinblastine—head and neck cancer	0.000311	0.00458	CcSEcCtD
Azelastine—Diarrhoea—Hydroxyurea—head and neck cancer	0.00031	0.00456	CcSEcCtD
Azelastine—Eye disorder—Docetaxel—head and neck cancer	0.000309	0.00456	CcSEcCtD
Azelastine—Flushing—Docetaxel—head and neck cancer	0.000307	0.00453	CcSEcCtD
Azelastine—Dizziness—Hydroxyurea—head and neck cancer	0.000299	0.00441	CcSEcCtD
Azelastine—Musculoskeletal discomfort—Fluorouracil—head and neck cancer	0.000297	0.00438	CcSEcCtD
Azelastine—Nausea—Vinblastine—head and neck cancer	0.000295	0.00435	CcSEcCtD
Azelastine—Paraesthesia—Fluorouracil—head and neck cancer	0.000293	0.00431	CcSEcCtD
Azelastine—Dyspnoea—Fluorouracil—head and neck cancer	0.000291	0.00428	CcSEcCtD
Azelastine—Somnolence—Fluorouracil—head and neck cancer	0.00029	0.00427	CcSEcCtD
Azelastine—Vomiting—Hydroxyurea—head and neck cancer	0.000288	0.00424	CcSEcCtD
Azelastine—Rash—Hydroxyurea—head and neck cancer	0.000286	0.00421	CcSEcCtD
Azelastine—Dermatitis—Hydroxyurea—head and neck cancer	0.000285	0.0042	CcSEcCtD
Azelastine—Headache—Hydroxyurea—head and neck cancer	0.000284	0.00418	CcSEcCtD
Azelastine—Dysgeusia—Docetaxel—head and neck cancer	0.000282	0.00416	CcSEcCtD
Azelastine—Back pain—Docetaxel—head and neck cancer	0.000279	0.00411	CcSEcCtD
Azelastine—Pain—Fluorouracil—head and neck cancer	0.000279	0.00411	CcSEcCtD
Azelastine—Nausea—Hydroxyurea—head and neck cancer	0.000269	0.00396	CcSEcCtD
Azelastine—Feeling abnormal—Fluorouracil—head and neck cancer	0.000269	0.00396	CcSEcCtD
Azelastine—Body temperature increased—Fluorouracil—head and neck cancer	0.000258	0.0038	CcSEcCtD
Azelastine—Palpitations—Docetaxel—head and neck cancer	0.000255	0.00375	CcSEcCtD
Azelastine—Cough—Docetaxel—head and neck cancer	0.000252	0.00371	CcSEcCtD
Azelastine—Hypertension—Docetaxel—head and neck cancer	0.000249	0.00367	CcSEcCtD
Azelastine—Myalgia—Docetaxel—head and neck cancer	0.000245	0.00362	CcSEcCtD
Azelastine—Chest pain—Docetaxel—head and neck cancer	0.000245	0.00362	CcSEcCtD
Azelastine—Hypersensitivity—Fluorouracil—head and neck cancer	0.00024	0.00354	CcSEcCtD
Azelastine—Dry mouth—Docetaxel—head and neck cancer	0.00024	0.00354	CcSEcCtD
Azelastine—Confusional state—Docetaxel—head and neck cancer	0.000237	0.00349	CcSEcCtD
Azelastine—Anaphylactic shock—Docetaxel—head and neck cancer	0.000235	0.00347	CcSEcCtD
Azelastine—Infection—Docetaxel—head and neck cancer	0.000234	0.00344	CcSEcCtD
Azelastine—Pruritus—Fluorouracil—head and neck cancer	0.000231	0.0034	CcSEcCtD
Azelastine—Tachycardia—Docetaxel—head and neck cancer	0.00023	0.00338	CcSEcCtD
Azelastine—Diarrhoea—Fluorouracil—head and neck cancer	0.000223	0.00329	CcSEcCtD
Azelastine—Dizziness—Fluorouracil—head and neck cancer	0.000216	0.00318	CcSEcCtD
Azelastine—Musculoskeletal discomfort—Docetaxel—head and neck cancer	0.000214	0.00316	CcSEcCtD
Azelastine—Paraesthesia—Docetaxel—head and neck cancer	0.000211	0.00311	CcSEcCtD
Azelastine—Dyspnoea—Docetaxel—head and neck cancer	0.00021	0.00309	CcSEcCtD
Azelastine—Somnolence—Docetaxel—head and neck cancer	0.000209	0.00308	CcSEcCtD
Azelastine—Vomiting—Fluorouracil—head and neck cancer	0.000207	0.00305	CcSEcCtD
Azelastine—Rash—Fluorouracil—head and neck cancer	0.000206	0.00303	CcSEcCtD
Azelastine—Dermatitis—Fluorouracil—head and neck cancer	0.000205	0.00303	CcSEcCtD
Azelastine—Headache—Fluorouracil—head and neck cancer	0.000204	0.00301	CcSEcCtD
Azelastine—Fatigue—Docetaxel—head and neck cancer	0.000203	0.00299	CcSEcCtD
Azelastine—Pain—Docetaxel—head and neck cancer	0.000201	0.00296	CcSEcCtD
Azelastine—Constipation—Docetaxel—head and neck cancer	0.000201	0.00296	CcSEcCtD
Azelastine—Feeling abnormal—Docetaxel—head and neck cancer	0.000194	0.00286	CcSEcCtD
Azelastine—Nausea—Fluorouracil—head and neck cancer	0.000194	0.00285	CcSEcCtD
Azelastine—Gastrointestinal pain—Docetaxel—head and neck cancer	0.000192	0.00283	CcSEcCtD
Azelastine—Abdominal pain—Docetaxel—head and neck cancer	0.000186	0.00274	CcSEcCtD
Azelastine—Body temperature increased—Docetaxel—head and neck cancer	0.000186	0.00274	CcSEcCtD
Azelastine—Hypersensitivity—Docetaxel—head and neck cancer	0.000173	0.00255	CcSEcCtD
Azelastine—Asthenia—Docetaxel—head and neck cancer	0.000169	0.00249	CcSEcCtD
Azelastine—Pruritus—Docetaxel—head and neck cancer	0.000166	0.00245	CcSEcCtD
Azelastine—Diarrhoea—Docetaxel—head and neck cancer	0.000161	0.00237	CcSEcCtD
Azelastine—Dizziness—Docetaxel—head and neck cancer	0.000156	0.00229	CcSEcCtD
Azelastine—Vomiting—Docetaxel—head and neck cancer	0.00015	0.0022	CcSEcCtD
Azelastine—Rash—Docetaxel—head and neck cancer	0.000148	0.00219	CcSEcCtD
Azelastine—Dermatitis—Docetaxel—head and neck cancer	0.000148	0.00218	CcSEcCtD
Azelastine—Headache—Docetaxel—head and neck cancer	0.000147	0.00217	CcSEcCtD
Azelastine—Nausea—Docetaxel—head and neck cancer	0.00014	0.00206	CcSEcCtD
Azelastine—ADRA1B—G alpha (q) signalling events—PIK3CA—head and neck cancer	3.17e-05	0.000619	CbGpPWpGaD
Azelastine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK3—head and neck cancer	3.1e-05	0.000607	CbGpPWpGaD
Azelastine—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—head and neck cancer	3.04e-05	0.000594	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—KISS1—head and neck cancer	3.01e-05	0.000588	CbGpPWpGaD
Azelastine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—head and neck cancer	2.95e-05	0.000577	CbGpPWpGaD
Azelastine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—head and neck cancer	2.95e-05	0.000577	CbGpPWpGaD
Azelastine—HRH3—Signaling Pathways—NOTCH1—head and neck cancer	2.9e-05	0.000567	CbGpPWpGaD
Azelastine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—head and neck cancer	2.89e-05	0.000564	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	2.88e-05	0.000562	CbGpPWpGaD
Azelastine—HRH1—G alpha (q) signalling events—PIK3CA—head and neck cancer	2.87e-05	0.00056	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—UROD—head and neck cancer	2.86e-05	0.000559	CbGpPWpGaD
Azelastine—CYP2A6—Metabolism—DPYD—head and neck cancer	2.84e-05	0.000555	CbGpPWpGaD
Azelastine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—head and neck cancer	2.83e-05	0.000553	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—GRP—head and neck cancer	2.74e-05	0.000535	CbGpPWpGaD
Azelastine—HRH3—Signaling by GPCR—MAPK3—head and neck cancer	2.72e-05	0.000531	CbGpPWpGaD
Azelastine—CYP2A6—Metabolism—YAP1—head and neck cancer	2.7e-05	0.000527	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—STAT6—head and neck cancer	2.66e-05	0.000519	CbGpPWpGaD
Azelastine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—head and neck cancer	2.62e-05	0.000512	CbGpPWpGaD
Azelastine—CYP2B6—Metabolism—NAT2—head and neck cancer	2.61e-05	0.000511	CbGpPWpGaD
Azelastine—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—head and neck cancer	2.61e-05	0.00051	CbGpPWpGaD
Azelastine—HRH3—Signaling by GPCR—MAPK1—head and neck cancer	2.59e-05	0.000506	CbGpPWpGaD
Azelastine—HRH3—Signaling by GPCR—EGFR—head and neck cancer	2.59e-05	0.000505	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	2.56e-05	0.000501	CbGpPWpGaD
Azelastine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—head and neck cancer	2.56e-05	0.000501	CbGpPWpGaD
Azelastine—CYP2E1—Metabolism—NAT2—head and neck cancer	2.56e-05	0.0005	CbGpPWpGaD
Azelastine—CYP3A5—Metabolism—NAT2—head and neck cancer	2.56e-05	0.000499	CbGpPWpGaD
Azelastine—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—head and neck cancer	2.52e-05	0.000492	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—GRP—head and neck cancer	2.48e-05	0.000484	CbGpPWpGaD
Azelastine—HRH3—GPCR downstream signaling—PIK3CA—head and neck cancer	2.47e-05	0.000483	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism—NAT2—head and neck cancer	2.41e-05	0.000472	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—STAT6—head and neck cancer	2.4e-05	0.00047	CbGpPWpGaD
Azelastine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—head and neck cancer	2.37e-05	0.000463	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—YAP1—head and neck cancer	2.35e-05	0.000459	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	2.35e-05	0.000459	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	2.33e-05	0.000455	CbGpPWpGaD
Azelastine—CYP2B6—Metabolism—DPYD—head and neck cancer	2.29e-05	0.000448	CbGpPWpGaD
Azelastine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—head and neck cancer	2.27e-05	0.000444	CbGpPWpGaD
Azelastine—CYP2E1—Metabolism—DPYD—head and neck cancer	2.25e-05	0.000439	CbGpPWpGaD
Azelastine—HRH3—Signaling by GPCR—PIK3CA—head and neck cancer	2.25e-05	0.000439	CbGpPWpGaD
Azelastine—CYP3A5—Metabolism—DPYD—head and neck cancer	2.24e-05	0.000438	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—NAT2—head and neck cancer	2.21e-05	0.000433	CbGpPWpGaD
Azelastine—CYP2B6—Metabolism—YAP1—head and neck cancer	2.18e-05	0.000425	CbGpPWpGaD
Azelastine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—head and neck cancer	2.15e-05	0.00042	CbGpPWpGaD
Azelastine—CYP2E1—Metabolism—YAP1—head and neck cancer	2.13e-05	0.000416	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—YAP1—head and neck cancer	2.13e-05	0.000416	CbGpPWpGaD
Azelastine—CYP3A5—Metabolism—YAP1—head and neck cancer	2.13e-05	0.000416	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism—DPYD—head and neck cancer	2.12e-05	0.000414	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	2.1e-05	0.00041	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	2.08e-05	0.000406	CbGpPWpGaD
Azelastine—HRH3—Signaling by GPCR—HRAS—head and neck cancer	2.08e-05	0.000406	CbGpPWpGaD
Azelastine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—head and neck cancer	2.05e-05	0.0004	CbGpPWpGaD
Azelastine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—head and neck cancer	2.05e-05	0.0004	CbGpPWpGaD
Azelastine—HRH3—GPCR downstream signaling—AKT1—head and neck cancer	2.02e-05	0.000395	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism—YAP1—head and neck cancer	2.01e-05	0.000393	CbGpPWpGaD
Azelastine—HRH3—Signaling Pathways—IL2—head and neck cancer	2e-05	0.00039	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—NAT2—head and neck cancer	1.98e-05	0.000386	CbGpPWpGaD
Azelastine—HRH3—Signaling Pathways—CCND1—head and neck cancer	1.95e-05	0.000381	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—DPYD—head and neck cancer	1.94e-05	0.000379	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—NAT2—head and neck cancer	1.93e-05	0.000377	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	1.91e-05	0.000374	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	1.89e-05	0.00037	CbGpPWpGaD
Azelastine—HRH3—Signaling Pathways—PTEN—head and neck cancer	1.88e-05	0.000367	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—YAP1—head and neck cancer	1.84e-05	0.00036	CbGpPWpGaD
Azelastine—HRH3—Signaling by GPCR—AKT1—head and neck cancer	1.83e-05	0.000358	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—NAT2—head and neck cancer	1.82e-05	0.000355	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—NAT2—head and neck cancer	1.8e-05	0.000352	CbGpPWpGaD
Azelastine—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—head and neck cancer	1.78e-05	0.000347	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—DPYD—head and neck cancer	1.73e-05	0.000339	CbGpPWpGaD
Azelastine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—head and neck cancer	1.72e-05	0.000336	CbGpPWpGaD
Azelastine—HRH3—Signaling Pathways—VEGFA—head and neck cancer	1.7e-05	0.000332	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—DPYD—head and neck cancer	1.69e-05	0.00033	CbGpPWpGaD
Azelastine—HRH3—Signaling Pathways—STAT3—head and neck cancer	1.68e-05	0.000329	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—YAP1—head and neck cancer	1.64e-05	0.000321	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	1.64e-05	0.000319	CbGpPWpGaD
Azelastine—CYP2A6—Metabolism—TYMS—head and neck cancer	1.62e-05	0.000316	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	1.62e-05	0.000316	CbGpPWpGaD
Azelastine—HRH3—Signaling Pathways—MAPK3—head and neck cancer	1.61e-05	0.000314	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—YAP1—head and neck cancer	1.6e-05	0.000314	CbGpPWpGaD
Azelastine—CYP2A6—Metabolism—GSTM1—head and neck cancer	1.6e-05	0.000313	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—DPYD—head and neck cancer	1.59e-05	0.000311	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—DPYD—head and neck cancer	1.58e-05	0.000309	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—NAT2—head and neck cancer	1.54e-05	0.000301	CbGpPWpGaD
Azelastine—CYP2A6—Metabolism—GPX1—head and neck cancer	1.53e-05	0.000299	CbGpPWpGaD
Azelastine—HRH3—Signaling Pathways—MAPK1—head and neck cancer	1.53e-05	0.000299	CbGpPWpGaD
Azelastine—HRH3—Signaling Pathways—EGFR—head and neck cancer	1.53e-05	0.000299	CbGpPWpGaD
Azelastine—CYP2A6—Metabolism—CYP1A1—head and neck cancer	1.52e-05	0.000296	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—YAP1—head and neck cancer	1.51e-05	0.000295	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	1.51e-05	0.000295	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—YAP1—head and neck cancer	1.5e-05	0.000293	CbGpPWpGaD
Azelastine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—head and neck cancer	1.45e-05	0.000284	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	1.38e-05	0.00027	CbGpPWpGaD
Azelastine—ADRA1B—GPCR downstream signaling—IL2—head and neck cancer	1.36e-05	0.000266	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—DPYD—head and neck cancer	1.35e-05	0.000264	CbGpPWpGaD
Azelastine—HRH3—Signaling Pathways—PIK3CA—head and neck cancer	1.33e-05	0.000259	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	1.32e-05	0.000257	CbGpPWpGaD
Azelastine—CYP2B6—Metabolism—TYMS—head and neck cancer	1.31e-05	0.000255	CbGpPWpGaD
Azelastine—CYP2B6—Metabolism—GSTM1—head and neck cancer	1.29e-05	0.000252	CbGpPWpGaD
Azelastine—HRH3—Signaling Pathways—TP53—head and neck cancer	1.28e-05	0.000251	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—YAP1—head and neck cancer	1.28e-05	0.00025	CbGpPWpGaD
Azelastine—CYP2E1—Metabolism—TYMS—head and neck cancer	1.28e-05	0.00025	CbGpPWpGaD
Azelastine—CYP3A5—Metabolism—TYMS—head and neck cancer	1.28e-05	0.00025	CbGpPWpGaD
Azelastine—CYP2E1—Metabolism—GSTM1—head and neck cancer	1.26e-05	0.000247	CbGpPWpGaD
Azelastine—CYP3A5—Metabolism—GSTM1—head and neck cancer	1.26e-05	0.000247	CbGpPWpGaD
Azelastine—CYP2B6—Metabolism—GPX1—head and neck cancer	1.24e-05	0.000242	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	1.24e-05	0.000241	CbGpPWpGaD
Azelastine—ADRA1B—Signaling by GPCR—IL2—head and neck cancer	1.23e-05	0.000241	CbGpPWpGaD
Azelastine—HRH1—GPCR downstream signaling—IL2—head and neck cancer	1.23e-05	0.00024	CbGpPWpGaD
Azelastine—HRH3—Signaling Pathways—HRAS—head and neck cancer	1.23e-05	0.00024	CbGpPWpGaD
Azelastine—CYP2B6—Metabolism—CYP1A1—head and neck cancer	1.22e-05	0.000239	CbGpPWpGaD
Azelastine—CYP2E1—Metabolism—GPX1—head and neck cancer	1.21e-05	0.000237	CbGpPWpGaD
Azelastine—CYP3A5—Metabolism—GPX1—head and neck cancer	1.21e-05	0.000236	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	1.21e-05	0.000236	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism—TYMS—head and neck cancer	1.21e-05	0.000236	CbGpPWpGaD
Azelastine—CYP2E1—Metabolism—CYP1A1—head and neck cancer	1.2e-05	0.000234	CbGpPWpGaD
Azelastine—CYP3A5—Metabolism—CYP1A1—head and neck cancer	1.2e-05	0.000234	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism—GSTM1—head and neck cancer	1.19e-05	0.000233	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—NAT2—head and neck cancer	1.19e-05	0.000232	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism—GPX1—head and neck cancer	1.14e-05	0.000223	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	1.13e-05	0.00022	CbGpPWpGaD
Azelastine—HRH1—Signaling by GPCR—IL2—head and neck cancer	1.12e-05	0.000218	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—TYMS—head and neck cancer	1.11e-05	0.000216	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—GSTM1—head and neck cancer	1.09e-05	0.000214	CbGpPWpGaD
Azelastine—HRH3—Signaling Pathways—AKT1—head and neck cancer	1.08e-05	0.000212	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	1.08e-05	0.000211	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—NOTCH1—head and neck cancer	1.06e-05	0.000207	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—GPX1—head and neck cancer	1.05e-05	0.000205	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—DPYD—head and neck cancer	1.04e-05	0.000204	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—CYP1A1—head and neck cancer	1.04e-05	0.000203	CbGpPWpGaD
Azelastine—ADRA1B—Signaling by GPCR—MAPK3—head and neck cancer	9.92e-06	0.000194	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—YAP1—head and neck cancer	9.89e-06	0.000193	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—TYMS—head and neck cancer	9.87e-06	0.000193	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	9.82e-06	0.000192	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—GSTM1—head and neck cancer	9.76e-06	0.000191	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—TYMS—head and neck cancer	9.64e-06	0.000188	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	9.63e-06	0.000188	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—NOTCH1—head and neck cancer	9.59e-06	0.000187	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—GSTM1—head and neck cancer	9.53e-06	0.000186	CbGpPWpGaD
Azelastine—ADRA1B—Signaling by GPCR—MAPK1—head and neck cancer	9.44e-06	0.000185	CbGpPWpGaD
Azelastine—ADRA1B—Signaling by GPCR—EGFR—head and neck cancer	9.44e-06	0.000184	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—GPX1—head and neck cancer	9.35e-06	0.000183	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	9.29e-06	0.000181	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—CYP1A1—head and neck cancer	9.25e-06	0.000181	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—GPX1—head and neck cancer	9.12e-06	0.000178	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—TYMS—head and neck cancer	9.08e-06	0.000177	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—CYP1A1—head and neck cancer	9.03e-06	0.000176	CbGpPWpGaD
Azelastine—CYP2A6—Metabolism—PTGS2—head and neck cancer	9.02e-06	0.000176	CbGpPWpGaD
Azelastine—ADRA1B—GPCR downstream signaling—PIK3CA—head and neck cancer	9.02e-06	0.000176	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—TYMS—head and neck cancer	9e-06	0.000176	CbGpPWpGaD
Azelastine—HRH1—Signaling by GPCR—MAPK3—head and neck cancer	8.98e-06	0.000176	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—GSTM1—head and neck cancer	8.98e-06	0.000175	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—GSTM1—head and neck cancer	8.9e-06	0.000174	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—GPX1—head and neck cancer	8.6e-06	0.000168	CbGpPWpGaD
Azelastine—HRH1—Signaling by GPCR—MAPK1—head and neck cancer	8.55e-06	0.000167	CbGpPWpGaD
Azelastine—HRH1—Signaling by GPCR—EGFR—head and neck cancer	8.55e-06	0.000167	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—GPX1—head and neck cancer	8.52e-06	0.000166	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	8.52e-06	0.000166	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—CYP1A1—head and neck cancer	8.51e-06	0.000166	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—CYP1A1—head and neck cancer	8.44e-06	0.000165	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	8.39e-06	0.000164	CbGpPWpGaD
Azelastine—ADRA1B—Signaling by GPCR—PIK3CA—head and neck cancer	8.19e-06	0.00016	CbGpPWpGaD
Azelastine—HRH1—GPCR downstream signaling—PIK3CA—head and neck cancer	8.17e-06	0.00016	CbGpPWpGaD
Azelastine—CYP2A6—Metabolism—PTEN—head and neck cancer	7.87e-06	0.000154	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—TYMS—head and neck cancer	7.69e-06	0.00015	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—GSTM1—head and neck cancer	7.6e-06	0.000149	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	7.6e-06	0.000149	CbGpPWpGaD
Azelastine—ADRA1B—Signaling by GPCR—HRAS—head and neck cancer	7.58e-06	0.000148	CbGpPWpGaD
Azelastine—HRH1—Signaling by GPCR—PIK3CA—head and neck cancer	7.42e-06	0.000145	CbGpPWpGaD
Azelastine—ADRA1B—GPCR downstream signaling—AKT1—head and neck cancer	7.37e-06	0.000144	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—IL2—head and neck cancer	7.29e-06	0.000142	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—GPX1—head and neck cancer	7.28e-06	0.000142	CbGpPWpGaD
Azelastine—CYP2B6—Metabolism—PTGS2—head and neck cancer	7.28e-06	0.000142	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—CYP1A1—head and neck cancer	7.21e-06	0.000141	CbGpPWpGaD
Azelastine—CYP2E1—Metabolism—PTGS2—head and neck cancer	7.13e-06	0.000139	CbGpPWpGaD
Azelastine—CYP3A5—Metabolism—PTGS2—head and neck cancer	7.12e-06	0.000139	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—CCND1—head and neck cancer	7.11e-06	0.000139	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	6.93e-06	0.000135	CbGpPWpGaD
Azelastine—HRH1—Signaling by GPCR—HRAS—head and neck cancer	6.86e-06	0.000134	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—PTEN—head and neck cancer	6.86e-06	0.000134	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism—PTGS2—head and neck cancer	6.72e-06	0.000131	CbGpPWpGaD
Azelastine—ADRA1B—Signaling by GPCR—AKT1—head and neck cancer	6.69e-06	0.000131	CbGpPWpGaD
Azelastine—HRH1—GPCR downstream signaling—AKT1—head and neck cancer	6.67e-06	0.00013	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—IL2—head and neck cancer	6.6e-06	0.000129	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—CCND1—head and neck cancer	6.44e-06	0.000126	CbGpPWpGaD
Azelastine—CYP2B6—Metabolism—PTEN—head and neck cancer	6.35e-06	0.000124	CbGpPWpGaD
Azelastine—CYP2E1—Metabolism—PTEN—head and neck cancer	6.22e-06	0.000122	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—PTEN—head and neck cancer	6.21e-06	0.000121	CbGpPWpGaD
Azelastine—CYP3A5—Metabolism—PTEN—head and neck cancer	6.21e-06	0.000121	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—VEGFA—head and neck cancer	6.2e-06	0.000121	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—PTGS2—head and neck cancer	6.16e-06	0.00012	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—STAT3—head and neck cancer	6.14e-06	0.00012	CbGpPWpGaD
Azelastine—HRH1—Signaling by GPCR—AKT1—head and neck cancer	6.06e-06	0.000118	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—TYMS—head and neck cancer	5.94e-06	0.000116	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	5.92e-06	0.000116	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—GSTM1—head and neck cancer	5.87e-06	0.000115	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism—PTEN—head and neck cancer	5.86e-06	0.000115	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—MAPK3—head and neck cancer	5.86e-06	0.000115	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—GPX1—head and neck cancer	5.62e-06	0.00011	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—VEGFA—head and neck cancer	5.61e-06	0.00011	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—MAPK1—head and neck cancer	5.58e-06	0.000109	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—EGFR—head and neck cancer	5.58e-06	0.000109	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—CYP1A1—head and neck cancer	5.56e-06	0.000109	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—STAT3—head and neck cancer	5.55e-06	0.000109	CbGpPWpGaD
Azelastine—CYP2A6—Metabolism—PIK3CA—head and neck cancer	5.55e-06	0.000108	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—PTGS2—head and neck cancer	5.5e-06	0.000107	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—PTEN—head and neck cancer	5.38e-06	0.000105	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—PTGS2—head and neck cancer	5.37e-06	0.000105	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—MAPK3—head and neck cancer	5.31e-06	0.000104	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—PTGS2—head and neck cancer	5.06e-06	9.89e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—MAPK1—head and neck cancer	5.05e-06	9.87e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—EGFR—head and neck cancer	5.05e-06	9.86e-05	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—PTGS2—head and neck cancer	5.02e-06	9.8e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—PIK3CA—head and neck cancer	4.84e-06	9.46e-05	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—PTEN—head and neck cancer	4.8e-06	9.37e-05	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—PTEN—head and neck cancer	4.68e-06	9.15e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—TP53—head and neck cancer	4.68e-06	9.15e-05	CbGpPWpGaD
Azelastine—CYP2A6—Metabolism—AKT1—head and neck cancer	4.54e-06	8.86e-05	CbGpPWpGaD
Azelastine—CYP2B6—Metabolism—PIK3CA—head and neck cancer	4.48e-06	8.75e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—HRAS—head and neck cancer	4.48e-06	8.75e-05	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—PTEN—head and neck cancer	4.41e-06	8.62e-05	CbGpPWpGaD
Azelastine—CYP2E1—Metabolism—PIK3CA—head and neck cancer	4.39e-06	8.57e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—PIK3CA—head and neck cancer	4.38e-06	8.56e-05	CbGpPWpGaD
Azelastine—CYP3A5—Metabolism—PIK3CA—head and neck cancer	4.38e-06	8.55e-05	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—PTEN—head and neck cancer	4.37e-06	8.55e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—PTGS2—head and neck cancer	4.29e-06	8.38e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—TP53—head and neck cancer	4.24e-06	8.28e-05	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism—PIK3CA—head and neck cancer	4.14e-06	8.08e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—HRAS—head and neck cancer	4.05e-06	7.92e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—AKT1—head and neck cancer	3.95e-06	7.73e-05	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—PIK3CA—head and neck cancer	3.79e-06	7.41e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—PTEN—head and neck cancer	3.74e-06	7.3e-05	CbGpPWpGaD
Azelastine—CYP2B6—Metabolism—AKT1—head and neck cancer	3.66e-06	7.15e-05	CbGpPWpGaD
Azelastine—CYP2E1—Metabolism—AKT1—head and neck cancer	3.58e-06	7e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—AKT1—head and neck cancer	3.58e-06	6.99e-05	CbGpPWpGaD
Azelastine—CYP3A5—Metabolism—AKT1—head and neck cancer	3.58e-06	6.99e-05	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—PIK3CA—head and neck cancer	3.38e-06	6.61e-05	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism—AKT1—head and neck cancer	3.38e-06	6.6e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—PTGS2—head and neck cancer	3.31e-06	6.46e-05	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—PIK3CA—head and neck cancer	3.3e-06	6.46e-05	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—PIK3CA—head and neck cancer	3.11e-06	6.08e-05	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—AKT1—head and neck cancer	3.1e-06	6.05e-05	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—PIK3CA—head and neck cancer	3.09e-06	6.03e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—PTEN—head and neck cancer	2.89e-06	5.64e-05	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—AKT1—head and neck cancer	2.77e-06	5.4e-05	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—AKT1—head and neck cancer	2.7e-06	5.27e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—PIK3CA—head and neck cancer	2.64e-06	5.15e-05	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—AKT1—head and neck cancer	2.54e-06	4.97e-05	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—AKT1—head and neck cancer	2.52e-06	4.93e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—AKT1—head and neck cancer	2.15e-06	4.21e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—PIK3CA—head and neck cancer	2.04e-06	3.98e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—AKT1—head and neck cancer	1.66e-06	3.25e-05	CbGpPWpGaD
